论文部分内容阅读
目的观察在常规治疗基础上应用硝普纳治疗顽固性心力衰竭患者的临床疗效。方法采用自身对照的方法,106例顽固性心力衰竭患者在常规治疗方法无效情况下加用硝普钠持续静脉点滴,治疗1周,比较治疗前后NYHA心功能级别、心/胸比、左室射血分数(left ventricular ejection fraction,LVEF)及左室舒张未期内径(left ventricular end diastolic,LVED)的变化。结果治疗1周后症状明显改善(总有效率91%),心/胸比、左室舒张未期内径较治疗前显著缩小(P<0.01),左室射血分数较治疗前显著增高(P<0.01)。结论硝普钠治疗顽固性心力衰竭疗效显著。
Objective To observe the clinical efficacy of sodium nitroprusside in patients with refractory heart failure on the basis of routine treatment. Methods One hundred and sixty patients with refractory heart failure were treated with continuous intravenous infusion of sodium nitroprusside for one week after the treatment of refractory heart failure. The NYHA functional class, cardiac / thoracic ratio, left ventricular ejection fraction Left ventricular ejection fraction (LVEF) and left ventricular end diastolic diameter (LVED). Results After 1 week of treatment, the symptoms were significantly improved (total effective rate was 91%), heart / chest ratio, and left ventricular diastolic diameter were significantly reduced (P <0.01), and left ventricular ejection fraction was significantly higher than before treatment (P <0.01). Conclusion Sodium nitroprusside is effective in treating refractory heart failure.